We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TNYA market cap is 309.22M. The company's latest EPS is USD -1.8218 and P/E is -2.50.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -31.3M | -34.55M | -33.72M | -35.1M | -30.92M |
| Net Income | -30.7M | -33.52M | -31.74M | -33.27M | -29.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -27.71M | -38.91M | -72.81M | -125.62M | -131.19M |
| Net Income | -26.23M | -38.4M | -72.72M | -123.67M | -124.08M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 226.31M | 278.95M | 245.34M | 220.75M | 193.4M |
| Total Liabilities | 29.98M | 35.57M | 29.93M | 30.81M | 28.51M |
| Total Equity | 196.33M | 243.38M | 215.41M | 189.94M | 164.88M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 38M | 148.16M | 314.19M | 278.95M | 170.52M |
| Total Liabilities | 8.7M | 8.72M | 35.66M | 35.57M | 31.09M |
| Total Equity | -43.74M | -81.32M | 278.53M | 243.38M | 139.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -81.74M | -104.42M | -30.29M | -56.51M | -80.15M |
| Investing | 77.68M | 83.65M | 8.06M | 33.15M | 63.63M |
| Financing | 281k | 77.77M | -501k | 3.68M | 3.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -24.1M | -35.45M | -60.81M | -104.42M | -102.07M |
| Investing | -5.58M | -7.01M | -238.56M | 83.65M | 48.72M |
| Financing | 30.51M | 147.27M | 208.97M | 77.77M | 4.05M |
| Market Cap | 309.22M |
| Price to Earnings Ratio | -2.50 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.8 |
| Price to Book Ratio | 2.23 |
| Dividend Yield | - |
| Shares Outstanding | 68.11M |
| Average Volume (1 week) | 146.45k |
| Average Volume (1 Month) | 240.78k |
| 52 Week Change | -33.63% |
| 52 Week High | 8.0914 |
| 52 Week Low | 1.66 |
| Spread (Intraday) | 0.32 (6.68%) |
| Company Name | Tenaya Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.tenayatherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
